Sign in

Brian Witherow

Chief Financial Officer at Six Flags Entertainment Corporation/NEW
Executive

About Brian Witherow

Brian C. Witherow (age 58) is Chief Financial Officer of Six Flags Entertainment Corporation (post Cedar Fair–Six Flags merger). He served as EVP & CFO of Cedar Fair since January 2012, joining Cedar Fair in 1995 after Arthur Andersen, with roles progressing through Corporate Treasurer (2004) and VP & Corporate Controller (2005). He holds a B.S. in Accounting from Miami University . As CFO, his recent commentary emphasizes synergy execution and disciplined cost control, including $120M identified cost synergies (50 realized in 2024; 70 in 2025) and targeted 3% reduction in operating expenses and SG&A (inflation-inclusive), excluding add-backs such as severance . Q3 2025 performance: adjusted EBITDA ~$550M on revenue $1.32B, with attendance up 1% YoY, highlighting bifurcation between outperforming and underperforming parks and margin-focused execution .

Past Roles

OrganizationRoleYearsStrategic Impact
Six Flags Entertainment Corporation (post-merger)Chief Financial Officer2024–Present (current)CFO of combined company, leading integration, cost synergy execution, and financial strategy
Cedar Fair Entertainment CompanyEVP & Chief Financial Officer2012–2024Led finance for park portfolio growth; executed strategic investments and supported 2006 Paramount Parks acquisition (prior roles)
Cedar Fair Entertainment CompanyVP & Corporate Controller2005–2012Corporate controller responsibilities prior to CFO promotion
Cedar Fair Entertainment CompanyCorporate Treasurer2004–2005Oversaw treasury functions
Cedar Fair Entertainment CompanyCorporate Director of Investor Relations1995–2004Investor relations leadership post-Arthur Andersen
Arthur AndersenAudit/AccountingPre-1995Public accounting foundation

External Roles

OrganizationRoleYearsStrategic Impact
Experience Investment Corp. (SPAC)Director/Director Nominee; Signatory to S-1/A and 10-K/A2019–2021Provided capital markets and M&A perspective to SPAC platform

Fixed Compensation

ComponentDetailPeriod/DateNotes
Base Salary$670,000 initial annual salaryEmployment agreement dated Oct 8, 2024Subject to annual Board review
Target Annual Bonus100% of base salaryFrom Oct 8, 2024Participates in Company annual bonus program
Annual Equity Grant (target)$2,750,000 target grant valueDuring agreement termAward terms determined by Board
Initial PSU Grant52,773 target sharesGranted under 2024 PlanPerformance-based; see Performance Compensation

Performance Compensation

MetricWeightingTarget/DefinitionActual/PayoutVesting/Performance Period
Adjusted EBITDA (PSUs)Not disclosedPSUs earn 0–200% of target based on Company Adjusted EBITDANot disclosedPerformance period ends Dec 31, 2026; vesting subject to continued employment
Annual Cash IncentiveNot disclosedBoard establishes goals (may include Adjusted EBITDA and other criteria)Not disclosedPaid in standard bonus cycle; employment on last day of year required (subject to agreement terms)

Notes:

  • The Company disclosed PSUs tied to Adjusted EBITDA with payout from 0% to 200% of target and determination after the performance period; specific targets/weightings for Witherow’s annual cash bonus were not disclosed in retrieved filings .

Equity Ownership & Alignment

ItemAmountNotes
Total Beneficial Ownership (shares)253,500Less than 1% of outstanding shares
Voting Power (sole/shared)251,101 sole; 2,399 sharedAs disclosed
Investment Power (sole/shared)222,038 sole; 2,399 sharedAs disclosed
Restricted Stock/RSUs counted in voting power29,063 sharesRSUs/restricted stock included for voting, not investment

Employment Terms

ProvisionTermsTriggers/PeriodEquity Treatment
Severance (pre-Jul 1, 2026 OR within 24 months post-Change in Control)Cash payment equal to 2.5× (base salary + target annual bonus); unpaid prior-year bonus; pro-rated current-year bonus; medical benefits continuation for 30 monthsInvoluntary termination without Cause or For Good ReasonFull and immediate vesting of all equity awards; performance awards paid at target
Severance (outside periods above)Cash payment equal to 1× (base salary + target annual bonus); pro-rated bonus; medical benefits continuation for 12 monthsInvoluntary termination without Cause or For Good ReasonOnly equity awards scheduled to vest within 18 months become fully vested
Release requirementSeverance subject to signing a release of claimsAll severance payments/benefitsAs disclosed

Potential Payments Table (as of Dec 31, 2024)

ScenarioEarned but Unpaid SalarySeveranceIncentive CompensationRSUs/Restricted StockPerformance UnitsHealth BenefitsTotal
Termination Without Cause/Disability or Resignation for Good Reason$29,370$2,512,500 (1)$183,915$6,163,273 (2)$635,771 (3)$60,654$9,585,483
Death$29,370$183,915$6,163,273 (2)$635,771 (3)$24,261$7,036,590
Qualifying Termination Within 24 Months Following Change in Control$29,370$2,512,500 (1)$183,915$6,163,273 (2)$635,771 (3)$60,654$9,585,483

(1) Severance based on post-merger 2024 salary and target cash incentive
(2) RSU/restricted stock acceleration per plan terms
(3) Performance unit treatment per plan terms

All amounts reflect Company disclosures of Named Executive Officers’ potential payments under specified separation scenarios as of year-end 2024 .

Investment Implications

  • Pay-for-performance alignment: Witherow’s equity mix includes PSUs tied to Adjusted EBITDA with 0–200% payout through 2026, indicating clear linkage of long-term awards to profitability and integration execution . Annual equity grants targeted at $2.75M and a 100% salary bonus target emphasize at-risk compensation .
  • Retention and change-in-control economics: Double-trigger CIC severance (2.5× base + bonus) with full equity vesting at target supports retention through integration while elevating downside protection; outside CIC/dated window, severance drops to 1× and equity vesting is limited to awards vesting within 18 months, moderating payout risk .
  • Insider selling pressure and 2026 performance horizon: PSU performance period ending Dec 31, 2026 is a potential unlock date; payout hinges on achieving Adjusted EBITDA goals, creating incentives to deliver cost and revenue synergies into 2026 .
  • Ownership alignment: Beneficial ownership of 253,500 shares (including 29,063 restricted shares counted for voting) signals alignment, though it represents less than 1% of outstanding shares .
  • Execution track record: CFO commentary and results underscore active cost management and synergy realization (hit $50M in 2024; on track for $70M in 2025; total $120M) and a plan to reduce operating expenses and SG&A by ~3% (inflation inclusive), supporting margin expansion thesis amid integration . Q3 2025 adjusted EBITDA ~$550M on $1.32B revenue evidences resilient profitability with targeted park-level strategy to address underperformers .

Performance context: Merger slides outlined a combined pro forma revenue of $3.4B and adjusted EBITDA of $1.2B with 36% margin including synergies (LTM Q3 2023), framing the integration opportunity set .